Kensey Nash’s Orthopedics Business Fortified By New Customers
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash inked major supply agreements in the second quarter, expanding the firm's customer base and accelerating the rebound of its biomaterials business
You may also be interested in...
Kensey Nash Looks To Augment TriActiv Embolic Protection Offerings
Kensey Nash is counting on the next-generation TriActiv Fx and TriActiv ProGuard embolic protection systems to substantially strengthen its endovascular business
Kensey Nash Predicts Orthopedic Growth In 2006 After Orthovita Disappoints
Kensey Nash expects that updating the Vitoss Foam bone-void filler line will revive sluggish sales to biomaterials company Orthovita in 2006
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.